EcoDrugPlus

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSBMSG00010010135
Gene Symbol: PPARG
1 Cross references
406 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta

Ensembl ID : ENSBMSG00010002220
Gene Symbol: PIK3CB
1 Cross references
216 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta

Ensembl ID : ENSBMSG00010006127
Gene Symbol: PIK3CD
1 Cross references
214 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma

Ensembl ID : ENSBMSG00010006704
Gene Symbol: PIK3CG
1 Cross references
215 Possible Orthologues:

Phosphodiesterase 10a

Ensembl ID : ENSBMSG00010010298
Gene Symbol: PDE10A
1 Cross references
207 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSBMSG00010007943
Gene Symbol: PDE3A
1 Cross references
258 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSBMSG00010011135
Gene Symbol: PDE3B
1 Cross references
204 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSBMSG00010011522
Gene Symbol: PDE4A
1 Cross references
250 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSBMSG00010003487
Gene Symbol: PDE4B
1 Cross references
298 Possible Orthologues:

Phosphodiesterase 4c

Ensembl ID : ENSBMSG00010004659
Gene Symbol: PDE4C
1 Cross references
88 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSBMSG00010006462
Gene Symbol: PDE4D
1 Cross references
235 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSBMSG00010022590
Gene Symbol: PDE5A
1 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).